Bide Pharmatech (688073.SH) has repurchased a total of 1.6162 million shares with a total investment of 70.4314 million yuan.
Bide Pharmaceutical (688073.SH) announced that as of February 29, 2024, the company has passed the Shanghai Securities...
Bide Pharmatech (688073.SH) announced that as of February 29, 2024, the company has repurchased a total of 1.6162 million shares through the Shanghai Stock Exchange trading system by means of centralized bidding trading. This represents 1.7783% of the company's total share capital. The highest repurchase price was 52.99 yuan/share, the lowest price was 32.36 yuan/share, and the total amount of the repurchase transaction was 70.4314 million yuan (excluding transaction costs).
Related Articles

Cinda: Global liquidity has tightened and the US dollar index may enter a period of wide fluctuations in the second half of the year.

New stock news | Yongkang Holdings passed the hearing of the Hong Kong Stock Exchange and operates 18 container yards at 10 locations.

CMSC: Short-term focus on copper prices tightening liquidity and changes in geopolitical risks. In the medium to long term, we still see the evolution of supply and demand patterns.
Cinda: Global liquidity has tightened and the US dollar index may enter a period of wide fluctuations in the second half of the year.

New stock news | Yongkang Holdings passed the hearing of the Hong Kong Stock Exchange and operates 18 container yards at 10 locations.

CMSC: Short-term focus on copper prices tightening liquidity and changes in geopolitical risks. In the medium to long term, we still see the evolution of supply and demand patterns.

RECOMMEND





